Showing results (451-460 of 586) with videos related to

Sort By:
Pageof 59
The Journal of Arthroplasty|April 11, 2025
Challenges in Meeting Centers for Medicare and Medicaid Services Patient-Reported Outcome Measures Collection Requirements and Patient Predictors of Substantial Clinical Benefit Achievement in Total Joint ArthroplastyNoah M Hodson, Phillip C McKegg, Alexander Driessche, et al.
The Journal of Biological Chemistry|February 20, 2003
Deletion of P1 arginine in a novel antithrombin variant (antithrombin London) abolishes inhibitory activity but enhances heparin affinity and is associated with early onset thrombosisSrikumar M Raja, Neetu Chhablani, Richard Swanson, et al.
Cancer Genetics and Cytogenetics|November 7, 2000
Reciprocal translocation (3;5)(q26;q22) and possible BCHE gene involvement in an unusual myelogenous disorder with both myeloproliferative and dysplastic featuresW Füreder, B Streubel, J H Jordan, et al.
Annals of Hematology|March 22, 2002
A comparative study on demographic, hematological, and cytogenetic findings and prognosis in acute myeloid leukemia with and without leukemia cutisH Agis, A Weltermann, C Fonatsch, et al.
Annals of Saudi Medicine|January 1, 1997
An overview of breast cancerA Ezzat, M Raja, A Rostom, et al.
BMC Cell Biology|December 2, 2009
Aberrant trafficking of NSCLC-associated EGFR mutants through the endocytic recycling pathway promotes interaction with SrcByung Min Chung, Srikumar M Raja, Robert J Clubb, et al.
Annals of Hematology|July 12, 2001
Survival analysis and AML development in patients with de novo myelodysplastic syndromes: comparison of six different prognostic scoring systemsW R Sperr, F Wimazal, M Kundi, et al.
Immunology|April 1, 1996
Comparative immunophenotypic analysis of human mast cells, blood basophils and monocytesH Agis, W Füreder, H C Bankl, et al.
British Journal of Haematology|July 1, 1996
Graft failure after donor leucocyte infusion in relapsed chronic myeloid leukaemia: successful treatment with cyclophosphamide and antithymocyte globulin followed by peripheral blood stem cell infusionF Keil, P Kalhs, O A Haas, et al.
Annals of Hematology|April 1, 1996
Duration of second complete remission in patients with acute myeloid leukemia treated with chemotherapy: a retrospective single-center studyF Thalhammer, K Geissler, U Jäger, et al.
Pageof 59